These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 37809676)

  • 21. Material and tablet properties of pregelatinized (thermally modified) Dioscorea starches.
    Odeku OA; Schmid W; Picker-Freyer KM
    Eur J Pharm Biopharm; 2008 Sep; 70(1):357-71. PubMed ID: 18562187
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of starch 1500 as a binder and disintegrant in lamivudine tablets prepared by high shear wet granulation.
    Rahman BM; Ibne-Wahed MI; Khondkar P; Ahmed M; Islam R; Barman RK; Islam MA
    Pak J Pharm Sci; 2008 Oct; 21(4):455-9. PubMed ID: 18930870
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clay nanotubes as a novel multifunctional excipient for the development of directly compressible diclofenac potassium tablets in a SeDeM driven QbD environment.
    Ahmed FR; Shoaib MH; Yousuf RI; Ali T; Geckeler KE; Siddiqui F; Ahmed K; Qazi F
    Eur J Pharm Sci; 2019 May; 133():214-227. PubMed ID: 30951825
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A methodological evaluation and predictive in silico investigation into the multi-functionality of arginine in directly compressed tablets.
    ElShaer A; Kaialy W; Akhtar N; Iyire A; Hussain T; Alany R; Mohammed AR
    Eur J Pharm Biopharm; 2015 Oct; 96():272-81. PubMed ID: 26255158
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Application of Co-processed Excipient as a Novel Method to Compound Orally Disintegrating Tablets.
    Liew KB; Hii SH; Chew YL; Ming LC; Uddin AH; Sarker ZI
    Int J Pharm Compd; 2022; 26(3):255-263. PubMed ID: 35657749
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmaceutical Assessment of
    Owusu FWA; Boakye-Gyasi ME; Johnson R; Osei YA; Asante E; Bruce Otu DA; Ansong JA; Entsie P; Bayor MT
    ScientificWorldJournal; 2022; 2022():9810099. PubMed ID: 35401058
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of three chitin metal silicate co-precipitates as a potential multifunctional single excipient in tablet formulations.
    Hamid RA; Al-Akayleh F; Shubair M; Rashid I; Remawi MA; Badwan A
    Mar Drugs; 2010 May; 8(5):1699-715. PubMed ID: 20559493
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of Disintegrant-addition Methods on the Compounding of Orodispersible Tablets.
    Mahesparan VA; Bin Abd Razak FS; Ming LC; Uddin AH; Sarker MZI; Bin LK
    Int J Pharm Compd; 2020; 24(2):148-155. PubMed ID: 32196477
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of Acid-Modified Ethiopian Potato (
    Gulla A; Getachew A; Haile TG; Molla F
    Biomed Res Int; 2020; 2020():9325173. PubMed ID: 32337284
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of sodium starch glycolate, croscarmellose sodium and crospovidone on disintegration and dissolution of stevia-loaded tablets.
    Yousaf AM; Naheed F; Shahzad Y; Hussain T; Mahmood T
    Polim Med; 2019; 49(1):19-26. PubMed ID: 31756060
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of Preflo modified starches as new direct compression excipients. I. Tabletting characteristics.
    Sanghvi PP; Collins CC; Shukla AJ
    Pharm Res; 1993 Nov; 10(11):1597-603. PubMed ID: 8290472
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A study of a novel coprocessed dry binder composed of α-lactose monohydrate, microcrystalline cellulose and corn starch.
    Mužíková J; Srbová A; Svačinová P
    Pharm Dev Technol; 2017 Dec; 22(8):964-971. PubMed ID: 26758475
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Performance Evaluation of a Novel Biosourced Co-Processed Excipient in Direct Compression and Drug Release.
    Benabbas R; Sanchez-Ballester NM; Aubert A; Sharkawi T; Bataille B; Soulairol I
    Polymers (Basel); 2021 Mar; 13(6):. PubMed ID: 33807048
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of processing methods on xylitol-starch base co-processed adjuvant for orally disintegrating tablet application.
    Bin LK; Helaluddin ABM; Islam Sarker MZ; Mandal UK; Gaurav A
    Pak J Pharm Sci; 2020 Mar; 33(2):551-559. PubMed ID: 32276897
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of cellulose II powders as a potential multifunctional excipient in tablet formulations.
    de la Luz Reus Medina M; Kumar V
    Int J Pharm; 2006 Sep; 322(1-2):31-5. PubMed ID: 16828996
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative binding and disintegrating property of Echinochloa colona starch (difra starch) against maize, sorghum, and cassava starch.
    Abdallah DB; Charoo NA; Elgorashi AS
    Pharm Biol; 2014 Aug; 52(8):935-43. PubMed ID: 24552302
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Beta-cyclodextrin as a direct compression excipient compared to conventional ones.
    Saleh SI
    J Pharm Belg; 1993; 48(5):371-7. PubMed ID: 8120790
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of Acid Hydrolyzed Taro Boloso-I (
    Gashaw S; Getachew A; Mola F
    Adv Pharmacol Pharm Sci; 2024; 2024():6560070. PubMed ID: 38840752
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of co-processed excipient type on properties of orodispersible tablets containing captopril, tramadol, and domperidone.
    Tranová T; Loskot J; Navrátil O; Brniak W; Mužíková J
    Int J Pharm; 2023 Apr; 636():122838. PubMed ID: 36921743
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The influence of the API properties on the ODTs manufacturing from co-processed excipient systems.
    Krupa A; Jachowicz R; Pędzich Z; Wodnicka K
    AAPS PharmSciTech; 2012 Dec; 13(4):1120-9. PubMed ID: 22941425
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.